MCID: ERY017
MIFTS: 49

Erythema Elevatum Diutinum malady

Categories: Rare diseases, Skin diseases, Cardiovascular diseases, Bone diseases

Aliases & Classifications for Erythema Elevatum Diutinum

About this section
Sources:
11Disease Ontology, 13DISEASES, 30ICD10, 31ICD10 via Orphanet, 39MeSH, 40MESH via Orphanet, 48NIH Rare Diseases, 54Orphanet, 68UMLS, 69UMLS via Orphanet
See all MalaCards sources

Aliases & Descriptions for Erythema Elevatum Diutinum:

Name: Erythema Elevatum Diutinum 11 48 54 39 13 68

Characteristics:

Orphanet epidemiological data:

54
erythema elevatum diutinum:
Age of onset: All ages; Age of death: normal life expectancy

Classifications:



External Ids:

Disease Ontology11 DOID:0060567
ICD1030 L95.1
MeSH39 C535509
Orphanet54 ORPHA90000
ICD10 via Orphanet31 L95.1
MESH via Orphanet40 C535509
UMLS via Orphanet69 C0263398

Summaries for Erythema Elevatum Diutinum

About this section
NIH Rare Diseases:48 Erythema elevatum diutinum is a rare type of chronic cutaneous vasculitis characterized by red, purple, brown or yellow papules, plaques (thick, red patches of skin), or nodules.these lesions are located mainly on the knees, elbows, hands, feet, face, genitals and buttocks. although it is a chronic condition, most cases respond well to treatment with dapsone. the cause of this condition remains unknown.  last updated: 4/13/2010

MalaCards based summary: Erythema Elevatum Diutinum is related to vasculitis and arthritis, and has symptoms including Array, Array and Array. An important gene associated with Erythema Elevatum Diutinum is CXCL8 (C-X-C Motif Chemokine Ligand 8), and among its related pathways are Primary immunodeficiency and Development and heterogeneity of the ILC family. Affiliated tissues include skin, bone and neutrophil, and related mouse phenotypes are cellular and hematopoietic system.

Disease Ontology:11 A vasculitis characterised by red, purple, brown or yellow papules (raised spot), plaques, or nodules, found on the backs of the hands, other extensor surfaces overlying joints, and on the buttocks.

Wikipedia:71 Erythema elevatum diutinum is a form of vasculitis. more...

Related Diseases for Erythema Elevatum Diutinum

About this section

Diseases related to Erythema Elevatum Diutinum via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50)    (show all 173)
idRelated DiseaseScoreTop Affiliating Genes
1vasculitis10.4
2arthritis10.3
3rheumatoid arthritis10.3
4fallopian tube carcinoma10.3CD79A, CXCL8
5plantar wart10.3CD79A, CXCL8
6keratitis10.2
7alcoholic neuropathy10.2CD40LG, CD79A
8camptodactyly vertebral fusion10.2CD40LG, CD79A
9spinal polio10.2CD40LG, CD79A
10rabies10.2CD40LG, CD79A
11unilateral retinoblastoma10.2CD40LG, CD79A
12delta chain disease10.2CD40LG, CD79A
13discitis10.2CD40LG, CD79A
14spinal canal and spinal cord meningioma10.2CD40LG, CD79A
15trichostrongyloidiasis10.2CD40LG, CD79A
16colloid adenoma10.2CD40LG, CD79A
17heart septal defect10.2CD40LG, CD79A
18cutaneous polyarteritis nodosa10.2CD40LG, CD79A
19mild pre-eclampsia10.2CD40LG, CD79A
20retinal microaneurysm10.2CD40LG, CD79A
21pediatric meningioma10.2CD40LG, CD79A
22tonsil cancer10.2CD40LG, CD79A
23indomethacin antenatal infection10.2CD40LG, CD79A
24postcricoid region cancer10.2CD40LG, CD79A
25acute kidney tubular necrosis10.2CD40LG, CD79A
26atheroembolism of kidney10.2CD40LG, CD79A
27partial sensory epilepsy10.2CD40LG, CD79A
28diabetic angiopathy10.2CD40LG, CD79A
29endocarditis10.2CD40LG, CD79A
30muscular dystrophy10.2CD40LG, CD79A
31dumping syndrome10.2CD40LG, CD79A
32striatonigral degeneration10.2CD40LG, CD79A
33ciliary body spindle cell melanoma10.2CD40LG, CD79A
34purulent endophthalmitis10.2CD40LG, CD79A
35mu chain disease10.2CD40LG, CD79A
36generalized atherosclerosis10.2CD40LG, CD79A
37bursitis10.2CD40LG, CD79A
38syphilis10.2CD40LG, CD79A
39homocystinuria10.2CD40LG, CD79A
40mental retardation, autosomal dominant 1910.2CD40LG, CD79A
41hemangioma of orbit10.2CD40LG, CD79A
42leiomyosarcoma10.2CD40LG, CD79A
43immunoglobulin beta deficiency10.2CD40LG, CD79A
44gestational diabetes10.2CD40LG, CD79A
45odontogenic myxoma10.2CD40LG, CD79A
46chronic mucocutaneous candidiasis10.2CD40LG, CD79A
47primary thrombocytopenia10.2CD40LG, CD79A
48alkhurma hemorrhagic fever10.2CD40LG, CD79A
49pedophilia10.2CD40LG, CD79A
50polyneuropathy due to drug10.2CD40LG, CD79A

Graphical network of the top 20 diseases related to Erythema Elevatum Diutinum:



Diseases related to erythema elevatum diutinum

Symptoms & Phenotypes for Erythema Elevatum Diutinum

About this section

Human phenotypes related to Erythema Elevatum Diutinum:

 54 64 (show all 8)
id Description HPO Frequency Orphanet Frequency HPO Source Accession
1 skin rash64 54 Very frequent (99-80%) HP:0000988
2 arthralgia64 54 Very frequent (99-80%) HP:0002829
3 myalgia64 54 Occasional (29-5%) HP:0003326
4 abnormal blistering of the skin64 54 Frequent (79-30%) HP:0008066
5 increased antibody level in blood64 54 Frequent (79-30%) HP:0010702
6 vasculitis in the skin64 54 Very frequent (99-80%) HP:0200029
7 skin nodule64 54 Occasional (29-5%) HP:0200036
8 skin vesicle64 54 Frequent (79-30%) HP:0200037

MGI Mouse Phenotypes related to Erythema Elevatum Diutinum according to GeneCards Suite gene sharing:

41
idDescriptionMGI Source AccessionScoreTop Affiliating Genes
1MP:00053847.6CD34, CD40LG, CD79A, GATA3, PECAM1, S100A9
2MP:00053977.2CD34, CD40LG, CD79A, F13A1, GATA3, PECAM1
3MP:00053767.2CD34, CD40LG, CD79A, F13A1, GATA3, PECAM1
4MP:00053876.7CD34, CD40LG, CD79A, GATA3, PECAM1, S100A9

Drugs & Therapeutics for Erythema Elevatum Diutinum

About this section

Drugs for Erythema Elevatum Diutinum (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50)    (show all 245)
idNameStatusPhaseClinical TrialsCas NumberPubChem Id
1
Heparinapproved, investigationalPhase 4, Phase 38489005-49-6772, 46507594
Synonyms:
101921-26-0
102-94-3
102785-31-9
104521-37-1
11078-24-3
11129-39-8
12656-11-0
2-o-sulfohexopyranuronosyl-(1->4)-2-deoxy-3-o-sulfo-2-(sulfoamino)hexopyranosyl-(1->4)-2-o-sulfohexopyranuronosyl-(1->4)-2-acetamido-2-deoxy-6-o-sulfohexopyranose
37324-73-5
6-[6-[6-[5-acetamido-4,6-dihydroxy-2-(sulfooxymethyl)oxan-3-yl]oxy-2-carboxy-4-hydroxy-5-sulfooxyoxan-3-yl]oxy-2-(hydroxymethyl)-5-(sulfoamino)-4-sulfooxyoxan-3-yl]oxy-3,4-dihydroxy-5-sulfooxyoxane-2-carboxylic acid
9041-08-1
9045-22-1
9075-96-1
913079-23-9
91449-79-5
AC1L19ZN
AC1L1ROY
ALFA 87-120
ALFA 87-163
ALFA 87-198
ALFA 87-81
ALFA 88-247
AR-1E4539
Allocinnamic acid
Ardeparin
Ardeparin sodium
Arteven
Bemiparin
Bemiparin sodium
CID772
CID8784
CY 216
Calciparine
Certoparin
Clexane
Clivarin
Clivarine
Cy 222
D006495
D017984
DB00407
DB01225
Dalteparin
Dalteparin sodium
Depo-Heparin
EINECS 232-681-7
EMT 966
EMT 967
EMT-966
EMT-967
EMT966
EMT967
Enoxaparin
Enoxaparin sodium
Enoxaparine
Eparina
Eparina [DCIT]
FR 860
Fluxum
Fragmin A
Fragmin B
Fragmin IV
Fraxiparin
H 2149
HSDB 3094
Hed-heparin
Hep Flush Kit in plastic container
Hep-Lock
Hep-Lock U/P
Hep-lock
Heparin
Heparin CY 216
Heparin Lock Flush
Heparin Lock Flush in plastic container
Heparin Lock Flush preservative free
Heparin Lock Flush preservative free in plastic container
Heparin Sodium
Heparin natrium
Heparin sodium
Heparin sodium 1,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 1,000 units in dextrose 5% in plastic container
Heparin sodium 1,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 10,000 units in dextrose 5%
Heparin sodium 10,000 units in dextrose 5% in plastic container
Heparin sodium 10,000 units in sodium chloride 0.45%
Heparin sodium 10,000 units in sodium chloride 0.9%
Heparin sodium 12,500 units in dextrose 5%
Heparin sodium 12,500 units in dextrose 5% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.45% in plastic container
Heparin sodium 12,500 units in sodium chloride 0.9%
Heparin sodium 2,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 2,000 units in dextrose 5% in plastic container
Heparin sodium 2,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 20,000 units and dextrose 5% in plastic container
Heparin sodium 20,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units and dextrose 5% in plastic container
 
Heparin sodium 25,000 units in dextrose 5%
Heparin sodium 25,000 units in dextrose 5% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.45% in plastic container
Heparin sodium 25,000 units in sodium chloride 0.9%
Heparin sodium 25,000 units in sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units and sodium chloride 0.9% in plastic container
Heparin sodium 5,000 units in dextrose 5% in plastic container
Heparin sodium 5,000 units in sodium chloride 0.45%
Heparin sodium 5,000 units in sodium chloride 0.9%
Heparin sodium 5,000 units in sodium chloride 0.9% in plastic container
Heparin sodium in plastic container
Heparin sodium preservative Free
Heparin sulfate
Heparin sulphate
Heparin, Low Molecular Weight
Heparin, Low-Molecular-Weight
Heparin, sodium salt
Heparina
Heparina [INN-Spanish]
Heparinate
Heparine
Heparine [INN-French]
Heparinic acid
Heparinsodiumsalt
Heparinum
Heparinum [INN-Latin]
Heparinum natricum
Hepathrom
Hepflush-10
Inno-Hep
Innohep
Isocinnamic acid
KB 101
Kabi 2165
LHN 1
LMWH
Lioton 1000
Lipo-hepin
Liquaemin
Liquaemin Lock Flush
Liquaemin Sodium
Liquaemin sodium preservative free
Liquemin
Logiparin
Lovenox
Lovenox HP
Low Molecular Weight Heparin
Low molecular weight heparin
Low molecular weight heparin sodium
Low-Molecular-Weight Heparin
Minolteparin sodium
MolPort-003-760-257
Multiparin
NSC174025
Nadroparin
Nadroparine
Novoheparin
OP 386
OP 622
Octaparin
PK 10,169
PK-10,169
PK-10169
PK10,169
PK10169
Pabyrin
Panheprin
Parnaparin
Parnaparin sodium
Parvoparin
Pularin
Reviparin
Reviparin sodium
Ro 11
Sandoparin
Sodium acid heparin
Sodium heparin
Sodium heparinate
Subeparin
Sublingula
Thromboliquine
Tinzaparin
Tinzaparin sodium
Triofiban
UNII-12M44VTJ7B
UNII-3S182ET3UA
UNII-E47C0NF7LV
UNII-T2410KM04A
UNII-ZZ45AB24CA
Unfractionated heparin
Vetren
Vitrum AB
WY 90493RD
alpha-Heparin
cis-.beta.-Carboxystyrene
cis-Cinnamic acid
enoxaparin
heparin
2
MethotrexateapprovedPhase 4, Phase 3, Phase 215511959-05-2, 59-05-2126941
Synonyms:
4-amino-10-methylfolic acid
4-amino-N(10)-methylpteroylglutamic acid
Abitrexate
Amethopterin
Amethopterine
Antifolan
Arbitrexate
Emtexate
Folex
HDMTX
L-Amethopterin
Ledertrexate
MTX
Metatrexan
 
Methopterin
Methotextrate
Methotrate
Methotrexat
Methotrexate Sodium
Methotrexatum
Methylaminopterin
Methylaminopterinum
Metotrexato
Mexate
Méthotrexate
N-Bismethylpteroylglutamic Acid
N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid
Rheumatrex
Trexall
3
Insulin AspartapprovedPhase 4, Phase 3442116094-23-616132418
Synonyms:
(AspB28)-human insulin
1024611-56-0
116094-23-6
139532-40-4
28(sup B)-L-Aspartic acid-insulin (human)
877034-90-7
AspB28-insulin (human)
Aspart
Aspart Insulin
Aspart insulin
B28-Asp-insulin
B28-Aspart-Insulin
INA-X 14
 
INA-X14
Insulin X14
Insulin aspart
Insulin aspart [USAN]
Insulin aspart protamine recombinant
Insulin aspart recombinant
Insulin, Asp(B28)
LS-185932
NovoLog
NovoMix 30
NovoRapid
NovoRapid 30 Mix
Novolog mix 70/30
UNII-D933668QVX
4
BudesonideapprovedPhase 443251333-22-363006, 5281004
Synonyms:
(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione
(4aR,4bS,5S,6aS,6bS,8R,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one
(R,S)-11b,16a,17,21,tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with buty raldehyde
(RS)-(11beta,16alpha)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione
(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde
(S)-16alpha,17-(Butylidenedioxy)-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione
16,17-Butylidenebis(oxy)-11-,21-dihydroxypregna-1,4-diene-3,20-dione
16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione
16alpha(R),17-(Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
16alpha-,17alpha--butylidenedioxypregna-1,4-diene-11beta-,21-diol-3,20-dione
51333-22-3
AC-4697
AC1L1DQE
AC1L1Y6Y
AC1L22VC
AC1MHWI7
B 7777
B7777_SIGMA
BPBio1_000523
BRD-A34299591-001-03-4
BRD-A82238138-001-01-7
BSPBio_000475
BSPBio_002160
Bidien
Bio-0010
Budecort Inhaler
Budenofalk
Budeson
Budesonide (JAN/USAN/INN)
Budesonide Easyhaler
Budesonide MMX
Budesonide [USAN:INN:BAN:JAN]
Budesonido
Budesonido [INN-Spanish]
Budesonidum
Budesonidum [INN-Latin]
Budiair
Budicort
C25H34O6
CCRIS 5230
CHEBI:3207
CHEBI:656601
CHEMBL1370
CID2462
CID3033890
CID40000
CID5281004
CID63006
CPD000058337
Cortivent
D00246
DB01222
Desowen
Dexbudesonide
Dexbudesonide [INN]
DivK1c_000475
EINECS 257-139-7
EINECS 257-160-1
EINECS 257-161-7
EU-0100174
Entocort
Entocort EC
Entocort EC (TN)
Giona Easyhaler
HMS1569H17
HMS1921I22
HMS2094I13
HMS501H17
Horacort
 
IDI1_000475
Inflammide
KBio1_000475
KBio3_001660
KBioGR_001361
LS-187734
LS-7235
Lopac0_000174
MAP-0010
MLS000028507
MLS001077323
MLS002207112
Micronyl
Miflonide
MolPort-002-529-265
MolPort-003-666-332
MolPort-003-986-909
NCGC00015165-03
NCGC00021318-03
NCGC00021318-06
NCGC00089747-02
NCGC00089747-03
NCGC00089747-04
NCGC00178789-01
NINDS_000475
Noex
Preferid
Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione
Prestwick0_000518
Prestwick1_000518
Prestwick2_000518
Prestwick3_000518
Prestwick_840
Pulmaxan
Pulmaxan turbohaler
Pulmicort
Pulmicort (TN)
Pulmicort Flexhaler
Pulmicort Nebuamp
Pulmicort Respules
Pulmicort Topinasal
Pulmicort Turbuhaler
Pulmicort turbuhaler
Respules
Rhinocort
Rhinocort Aqua
Rhinocort Turbuhaler
Rhinocort alpha
Rhinocort, Pulmicort , Entocort, Symbicort, Noex. Entocort EC, Budesonide
Rhinosol
S 1320
S-1320
S1286_Selleck
SAM002699898
SMR000058337
SPBio_000586
SPBio_002396
SPECTRUM1500813
ST51039033
Spectrum2_000623
Spectrum3_000620
Spectrum4_000821
Spectrum5_001738
Spirocort
TL8003397
Tridesilon
UDB
UNII-168L5HT37P
UNII-2HI1006KPH
UNII-Q3OKS62Q6X
Unit dose budesonide
ZINC03938751
ZINC04097286
budesonide
5
Insulin GlargineapprovedPhase 4528160337-95-1
Synonyms:
 
Insulin Glargine (rDNA origin)
Insulin glargine recombinant
6
ZincapprovedPhase 4, Phase 322967440-66-632051, 23994
Synonyms:
30Zn
Cinc
Zinc
Zinc ion
 
Zincum
Zink
Zn
Zn(ii)
Zn2+
7
CanagliflozinapprovedPhase 4109842133-18-0
Synonyms:
 
Canagliflozin anhydrous
8
Insulin-glulisineapprovedPhase 4106207748-29-6
Synonyms:
 
Insulin Glulisine (recombinant DNA origin)
Insulin glulisine recombinant
9
MetforminapprovedPhase 4, Phase 31803657-24-914219, 4091
Synonyms:
1,1-Dimethyl biguanide
1,1-Dimethylbiguanide
3-(diaminomethylidene)-1,1-dimethylguanidine
657-24-9
AC1L1HE4
AKOS000121065
Apo-Metformin
BIDD:GT0697
BPBio1_000009
BRD-K79602928-003-04-1
BSPBio_000007
BSPBio_002314
C07151
C4H11N5
CAS-1115-70-4
CCRIS 9321
CHEBI:6801
CHEMBL1431
CID4091
D04966
DB00331
DMGG
Diabetosan
Diabex
Dimethylbiguanid
Dimethylbiguanide
Dimethylbiguanidine
Dimethyldiguanide
Dimethylguanylguanidine
EINECS 211-517-8
Fluamine
Flumamine
Fortamet
Gen-Metformin
Glifage
Gliguanid
Glucophage
Glucophage XR
Glumetza
Glycon
HMS2089D19
HSCI1_000295
Haurymelin
Haurymellin
Islotin
KBio2_002310
KBio2_004878
KBio2_007446
KBio3_002790
KBioGR_002310
 
KBioSS_002312
LA-6023
LS-43899
Melbin
Metformin
Metformin (USAN/INN)
Metformin HCL
Metformin [USAN:INN:BAN]
Metformina
Metformina [DCIT]
Metformina [Spanish]
Metformine
Metformine [INN-French]
Metformine pamoate
Metforminum
Metforminum [INN-Latin]
Metiguanide
MolPort-002-929-560
MolPort-004-288-389
MolPort-005-767-418
Mylan-Metformin
N,N-Dimethylbiguanide
N,N-Dimethyldiguanide
N,N-Dimethylimidodicarbonimidic diamide
N,N-dimethylimidodicarbonimidic diamide
N1,N1-Dimethylbiguanide
NCGC00016564-01
NCGC00016564-02
NCGC00016564-03
NNDG
Novo-Metformin
Nu-Metformin
PMS-Metformin
Prestwick0_000004
Prestwick1_000004
Prestwick2_000004
Prestwick3_000004
Ran-Metformin
Ratio-Metformin
Riomet
S2483_Selleck
SPBio_001928
STK011633
Sandoz Metformin
Siofor
T5895664
Teva-Metformin
UNII-9100L32L2N
ZINC12859773
cMAP_000016
metformin
metformin hydrochloride
10
GoserelinapprovedPhase 423365807-02-547725, 5311128
Synonyms:
(2S)-N-[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-[(2S)-2-[(carbamoylamino)carbamoyl]pyrrolidin-1-yl]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-[(2-methylpropan-2-yl)oxy]-1-oxopropan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
AC1NSK1T
CID5311128
Goserelin
Goserelin acetate
 
HMS2089D16
HS-2015
ICI-118630
MolPort-006-823-831
ZD-9393
Zoladex
goserelin
11
Leuprolideapproved, investigationalPhase 429953714-56-03911, 657181
Synonyms:
(D-Leu(6),des-gly-NH2(10),pro-ethylamide(9))-gonadotropin-releasing hormone
5-oxoPro-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-ProNHC2H5 dihydrate
5-oxoprolylhistidyltryptophylseryltyrosylleucylleucyl-n5-(diaminomethylidene)ornithyl-n-ethylprolinamide
AC1L1GZK
AC1L9B44
AC1Q5OPO
AR-1G9354
C07612
CID3911
CID441410
D00989
D08113
Enantone
Enantone (TN)
I04-0109
L-Pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamide
L001094
 
L002030
Leuprolide
Leuprolide acetate
Leuprolide acetate (USAN)
Leuprorelin
Leuprorelin (INN)
Leuprorelin acetate (JAN)
Leuprorelina
Leuproreline
Leuprorelinum
Lupron (TN)
N-[1-[[1-[[1-[[1-[[1-[[1-[[5-(diaminomethylideneamino)-1-[2-(ethylcarbamoyl)pyrrolidin-1-yl]-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino]-3-hydroxy-1-oxopropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-3-(1H-imidazol-5-yl)-1-oxopropan-2-yl]-5-oxopyrrolidine-2-carboxamide
NSC377526
NSC746847
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-NHC2H5
PGlu-his-trp-ser-tyr-D-leu-leu-arg-pro-nhet
acetic acid
leuprolide
12
Folic Acidapproved, nutraceutical, vet_approvedPhase 4, Phase 3, Phase 2439259-30-36037
Synonyms:
(2S)-2-[[4-[(2-amino-4-oxo-1H-pteridin-6-yl)methylamino]benzoyl]amino]pentanedioic acid
01769_FLUKA
2d0k
33609-88-0
36653-55-1 (mono-potassium salt)
59-30-3
6484-89-5 (mono-hydrochloride salt)
AC-11682
AC1L1LNX
AI3-26387
AKOS000503224
ARONIS014410
Acfol (Spain)
Acide folique
Acide folique [INN-French]
Acido folico
Acido folico [INN-Spanish]
Acidum folicum
Acidum folicum [INN-Latin]
Acifolic
Antianemia factor
Apo-Folic
BIDD:ER0563
BIDD:GT0641
BIF0608
BPBio1_000654
BSPBio_000594
BSPBio_002338
C00504
C20H20N6O6
CAS-59-30-3
CCRIS 666
CHEBI:27470
CHEMBL1622
CID6037
CPD000471860
Cytofol
D00070
DB00158
DivK1c_000494
Dosfolat B activ
EINECS 200-419-0
F0043
F7876_SIAL
F7876_SIGMA
F8758_SIGMA
F8798_SIAL
F8890_SIGMA
FOL
Facid
Factor U
Folacid
Folacin
Folaemin
Folaemin [Netherlands]
Folan
Folasic (Australia)
Folate
Folbal
Folcidin
Folcidin (VAN)
Folcysteine
Foldine
Foldine [France]
Folettes
Foliamin
Folic
Folic acid
Folic acid (JP15/USP/INN)
Folic acid (TN)
Folic acid [BAN:INN:JAN]
Folic acid [INN:BAN:JAN]
Folic acid dihydrate
Folicet
Folicet (TN)
Folico
Folico (Italy)
Folina
Folina (Italy)
Folipac
Folsaeure
 
Folsan
Folsaure
Folsav
Folvite
Folvron
Glutamic acid, N-(p-(((2-amino-4-hydroxypyrimido(4,5-b)pyrazin-6-yl)methyl)amino)benzoyl)-, L
HMS1921D20
HMS2092N17
HMS501I16
HSDB 2002
IDI1_000494
InChI=1/C19H19N7O6/c20-19-25-15-14(17(30)26-19)23-11(8-22-15)7-21-10-3-1-9(2-4-10)16(29)24-12(18(31)32)5-6-13(27)28/h1-4,8,12,21H,5-7H2,(H,24,29)(H,27,28)(H,31,32)(H3,20,22,25,26,30)/t12-/m0/s
Incafolic
KBio1_000494
KBio2_001861
KBio2_004429
KBio2_006997
KBio3_001558
KBioGR_002222
KBioSS_001861
Kyselina listova
Kyselina listova [Czech]
LS-2157
Liver Lactobacillus casei factor
MLS001304016
MLS001335861
Millafol
Mission prenatal
Mittafol
MolPort-004-285-551
N-(4-(((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzo- yl)-L-glutamic acid
N-(4-((2-Amino-1,4-dihydro-4-oxo-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-(4-{[(2-Amino-4-oxo-3,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}benzoyl)-L-glutamic acid
N-(p-(((2-Amino-4-hydroxy-6-pteridinyl)methyl)amino)benzoyl)-L-glutamic acid
N-Pteroyl-L-glutamic acid
N-[(4-{[(2-Amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[(4-{[(2-amino-4-oxo-1,4-dihydropteridin-6-yl)methyl]amino}phenyl)carbonyl]-L-glutamic acid
N-[4-[[(2-Amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-glutamic acid
NCGC00016265-01
NCGC00142391-01
NINDS_000494
NSC 3073
Nifolin
Nifolin [Denmark]
Novofolacid
Novofolacid [Canada]
PGA
PGA (VAN)
Prestwick3_000627
Prestwick_230
PteGlu
Pteroyl-L-glutamate
Pteroyl-L-glutamic acid
Pteroyl-L-monoglutamate
Pteroyl-L-monoglutamic acid
Pteroylglutamate
Pteroylglutamic acid
Pteroylmonoglutamate
Pteroylmonoglutamic acid
SAM002264616
SDCCGMLS-0066738.P001
SMP2_000137
SMR000471860
SPBio_001357
SPECTRUM1502020
Serum Folate Level
Spectrum2_001459
Spectrum3_000749
Spectrum4_001751
Spectrum5_000602
Spectrum_001381
UNII-935E97BOY8
Usaf cb-13
Vitamin B11
Vitamin B9
Vitamin Bc
Vitamin Be
Vitamin M
bmse000299
folic acid
nchembio.108-comp10
13
leucovorinapproved, NutraceuticalPhase 4, Phase 3, Phase 2323558-05-954575, 6560146, 143
Synonyms:
(5-formyl-5,6,7,8-tetrahydropteroyl)glutamate
(6R,S)-5-Formyltetrahydrofolate
10-Formyl-7,8-dihydrofolate
10-Formyl-7,8-dihydrofolic acid
5-Formyl-5,6,7,8-tetrahydrofolate
5-Formyl-5,6,7,8-tetrahydrofolic acid
5-Formyl-5,6,7,8-tetrahydropteroyl-L-glutamic acid
5-Formyltetrahydrofolate
5-Formyltetrahydrofolic acid
5-Formyltetrahydropteroylglutamate
5-Formyltetrahydropteroylglutamic acid
5-formyltetrahydrofolic acid
Acide folinique
Calcium citrovorum factor
Calcium folinate
Citrovorum factor
Folinate
Folinic acid
Folinic acid calcium salt
 
Folinic acid calcium salt USP27
Folinic acid-SF
L(-)-5-Formyl-5,6,7,8-tetrahydrofolic acid
L-Leucovorin
L-N-[p-[[(2-Amino-5-formyl-5,6,7,8-tetrahydro-4-hydroxy-6-pteridinyl)methyl]amino]benzoyl]-Glutamic acid
L-leucovorin
Leucal
Leucovorin calcium
Leucovorin folinic acid
Leucovorinum
Leukovorin
Levoleucovorin
N-(5-formyl-5,6,7,8-tetrahydropteroyl)-L-glutamic acid
N5-Formyl-5,6,7,8-tetrahydrofolate
N5-Formyl-5,6,7,8-tetrahydrofolic acid
N5-Formyl-THF
N5-Formyltetrahydrofolate
N5-Formyltetrahydrofolic acid
Welcovorin
Wellcovorin
folinate
14Hormone AntagonistsPhase 4, Phase 3, Phase 213180
15calcium heparinPhase 4, Phase 3848
16Nucleic Acid Synthesis InhibitorsPhase 4, Phase 3, Phase 24962
17Vitamin B ComplexPhase 4, Phase 3, Phase 24337
18Contraceptive AgentsPhase 4, Phase 31967
19Antineoplastic Agents, HormonalPhase 4, Phase 3, Phase 25592
20Antimetabolites, AntineoplasticPhase 4, Phase 3, Phase 27361
21AntimetabolitesPhase 4, Phase 3, Phase 212054
22HormonesPhase 4, Phase 3, Phase 214415
23Antirheumatic AgentsPhase 4, Phase 3, Phase 210956
24Folic Acid AntagonistsPhase 4, Phase 3, Phase 22257
25Dermatologic AgentsPhase 4, Phase 3, Phase 25806
26Immunosuppressive AgentsPhase 4, Phase 3, Phase 213086
27Hormones, Hormone Substitutes, and Hormone AntagonistsPhase 4, Phase 3, Phase 213168
28Adrenergic AgentsPhase 4, Phase 35352
29Carboxymethylcellulose SodiumPhase 4185
30Gastrointestinal AgentsPhase 4, Phase 3, Phase 28402
31LaxativesPhase 4537
32ProtaminesPhase 4, Phase 3181
33CatharticsPhase 4537
34Pharmaceutical SolutionsPhase 48192
35Budesonide, Formoterol Fumarate Drug CombinationPhase 4173
36Formoterol FumaratePhase 4438
37glucocorticoidsPhase 4, Phase 3, Phase 25103
38Neurotransmitter AgentsPhase 4, Phase 3, Phase 218340
39Autonomic AgentsPhase 4, Phase 3, Phase 210150
40Anti-Inflammatory AgentsPhase 4, Phase 3, Phase 210729
41Adrenergic AgonistsPhase 4, Phase 33027
42Adrenergic beta-2 Receptor AgonistsPhase 4957
43Adrenergic beta-AgonistsPhase 41714
44Anti-Asthmatic AgentsPhase 4, Phase 33488
45Peripheral Nervous System AgentsPhase 4, Phase 3, Phase 223689
46Bronchodilator AgentsPhase 4, Phase 32965
47insulinPhase 4, Phase 34646
48Insulin aspart, insulin aspart protamine drug combination 30:70Phase 4, Phase 3106
49Insulin, Globin ZincPhase 4, Phase 34645
50Insulin, Long-ActingPhase 4, Phase 3362

Interventional clinical trials:

(show top 50)    (show all 85)
idNameStatusNCT IDPhase
1Study to Evaluate the Mastery of Inhaler Technique for Budesonide Formoterol (BF) SPIROMAX® as Compared to SYMBICORT® TURBOHALER® as Treatment for Adult Patients With AsthmaCompletedNCT02062463Phase 4
2A Study of the Effects of Canagliflozin (JNJ-28431754) on Renal Endpoints in Adult Participants With Type 2 Diabetes MellitusCompletedNCT01989754Phase 4
3Comparison of a Basal Plus One Insulin Regimen With a Biphasic Insulin Regimen in Type 2 Diabetes PatientsCompletedNCT00965549Phase 4
4Local Phase 4 Pan-European SMART StudyCompletedNCT00463866Phase 4
5AQUACEL® Ag Dressing and Urgotul® Silver Dressing on Healing of Chronic Venous Leg UlcersCompletedNCT01084577Phase 4
6A Study of RoActemra/Actemra (Tocilizumab) in Combination With Methotrexate in Patients With Severe Active Rheumatoid Arthritis, Comparing Tapering Versus Maintaining the Methotrexate DosageTerminatedNCT01661140Phase 4
7GP Extended Action TriptorelinTerminatedNCT01673984Phase 4
8Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast CancerUnknown statusNCT00559858Phase 3
9Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate CancerUnknown statusNCT00392535Phase 3
10Dalteparin in Preventing Blood Clots in Patients With Lung CancerUnknown statusNCT00519805Phase 3
11Combination Chemotherapy With or Without Cetuximab as First-Line Therapy in Treating Patients With Metastatic Colorectal CancerUnknown statusNCT00182715Phase 3
12Apixaban for the Prevention of Stroke in Subjects With Atrial FibrillationCompletedNCT00412984Phase 3
13A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular DiseaseCompletedNCT00501059Phase 3
14A Study of Sativex® for Relieving Persistent Pain in Patients With Advanced CancerCompletedNCT01262651Phase 3
15High Dose Folic Acid Supplementation Throughout Pregnancy for Preeclampsia PreventionCompletedNCT01355159Phase 3
16A Study of GT267-004 Versus Vancomycin and GT267-004 Versus Metronidazole in Patients With C. Difficile-Associated DiarrheaCompletedNCT00196794Phase 3
17A Study of RoActemra/Actemra (Tocilizumab) in Monotherapy or in Combination With Methotrexate or Other Non-Biologic DMARDs in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biologic DMARD Therapy or the First Anti-TNF CompletedNCT02046603Phase 3
18Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential HypertensionCompletedNCT01788358Phase 3
19Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated RiskCompletedNCT01764633Phase 3
20A Two-Part Study of Sativex® Oromucosal Spray for Relieving Uncontrolled Persistent Pain in Patients With Advanced CancerCompletedNCT01424566Phase 3
21Dual Action of Liraglutide and Insulin Degludec in Type 2 Diabetes: A Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide, Insulin Degludec and Liraglutide in Subjects With Type 2 DiabetesCompletedNCT01336023Phase 3
22Study to Evaluate the Effect of Fluticasone Furoate/Vilanterol on Survival in Subjects With Chronic Obstructive Pulmonary DiseaseCompletedNCT01313676Phase 3
23An Extension to Study MA21573, Evaluating Tocilizumab in Patients With Active Rheumatoid Arthritis and an Inadequate Response to Current Non-Biological DMARDs and/or Anti-tumor Necrosis Factor (TNF) TherapyCompletedNCT00883753Phase 3
24An Exploratory Study of Tocilizumab in Patients With Active Rheumatoid Arthritis (RA) and an Inadequate Response to Current Non-Biologic DMARDs and/or Anti-TNF Therapy.CompletedNCT00750880Phase 3
25Safety and Efficacy of Linagliptin (BI 1356) as Monotherapy or in Combination in Type 2 DMCompletedNCT00736099Phase 3
26Efficacy and Safety of Dapagliflozin in Combination With Metformin in Type 2 Diabetes PatientsCompletedNCT00660907Phase 3
27BI 1356 (Linagliptin) in Combination With Metformin and a Sulphonylurea in Type 2 DiabetesCompletedNCT00602472Phase 3
28Respimat® Combivent Trial in Chronic Obstructive Pulmonary Disease (COPD)CompletedNCT00400153Phase 3
29Comparison of Insulin Detemir, Insulin Aspart and Biphasic Insulin Aspart 30 With OAD Treatment in Type 2 DiabetesCompletedNCT00184600Phase 3
30A Study of Xeloda (Capecitabine) Plus Oxaliplatin in Patients With Colon CancerCompletedNCT00069121Phase 3
31Dexmedetomidine Versus Propofol for Continuous Sedation in the Intensive Care Unit (ICU)CompletedNCT00479661Phase 3
32A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated PainCompletedNCT01439100Phase 3
33Long Term Safety of Sativex® Oromucosal Spray (Sativex®; Nabiximols) as Adjunctive Therapy in Patients With Uncontrolled Persistent Chronic Cancer Related PainCompletedNCT01337089Phase 3
34A Randomised Evaluation of Molecular Guided Therapy for Diffuse Large B-cell Lymphoma With BortezomibCompletedNCT01324596Phase 3
35Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary EmbolismCompletedNCT00633893Phase 3
36Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesCompletedNCT00454480Phase 2, Phase 3
37Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid TumoursRecruitingNCT02804815Phase 3
38Filgotinib in Long-Term Extension Study of Adults With Crohn's DiseaseRecruitingNCT02914600Phase 3
39Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's DiseaseRecruitingNCT02914561Phase 3
40Filgotinib in Long-Term Extension Study of Adults With Ulcerative ColitisRecruitingNCT02914535Phase 3
41Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Ulcerative ColitisRecruitingNCT02914522Phase 3
42A Study to Assess the Efficacy and Safety of the Gastric-retentive AP-CD/LD in Advanced Parkinson's PatientsRecruitingNCT02605434Phase 3
43An Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's DiseaseRecruitingNCT02542696Phase 3
44Efficacy and Safety of Two Different Aflibercept Regimens in Subjects With Neovascular Age-related Macular Degeneration (nAMD)RecruitingNCT02540954Phase 3
45Open-Label Extension and Safety Study for Patients With Crohn's Disease Previously Enrolled in the Etrolizumab Phase III Study GA29144RecruitingNCT02403323Phase 3
46A Study of the Safety and Efficacy of Etrolizumab in Patients With Moderately to Severely Active Crohn's DiseaseRecruitingNCT02394028Phase 3
47A Study Comparing the Efficacy and Safety of Etrolizumab to Infliximab in Participants With Moderate to Severe Ulcerative Colitis Who Are Naïve to Tumor Necrosis Factor (TNF) InhibitorsRecruitingNCT02136069Phase 3
48Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III StudiesRecruitingNCT02118584Phase 3
49A Study of the Efficacy and Safety of Etrolizumab in Ulcerative Colitis Participants Who Are Refractory to or Intolerant of Tumor Necrosis Factor (TNF) InhibitorsRecruitingNCT02100696Phase 3
50Efficacy and Safety Study of Sirukumab in Patients With Giant Cell ArteritisRecruitingNCT02531633Phase 3

Search NIH Clinical Center for Erythema Elevatum Diutinum


Cochrane evidence based reviews: erythema elevatum diutinum

Genetic Tests for Erythema Elevatum Diutinum

About this section

Anatomical Context for Erythema Elevatum Diutinum

About this section

MalaCards organs/tissues related to Erythema Elevatum Diutinum:

36
Skin, Bone, Neutrophil, B cells, Breast, Liver, Thyroid

Publications for Erythema Elevatum Diutinum

About this section

Articles related to Erythema Elevatum Diutinum:

(show top 50)    (show all 183)
idTitleAuthorsYear
1
A rare case of erythema elevatum diutinum presenting as diffuse neuropathy. (28050587)
2017
2
Erythema elevatum diutinum in association with IgA monoclonal gammopathy: A rare case report. (27559509)
2016
3
Chronic Localized Fibrosing Leukocytoclastic Vasculitis Associated With Lymphedema, Intralymphatic and Intravascular Lymphocytosis, and Chronic Myelogenous Leukemia: A Case Report of Unilateral Erythema Elevatum Diutinum. (27930381)
2016
4
Erythema elevatum diutinum in acquired immune deficiency syndrome: Can it be an immune reconstitution inflammatory syndrome? (27190420)
2016
5
Granuloma Faciale and Erythema Elevatum Diutinum in Relation to Immunoglobulin G4-Related Disease: An Appraisal of 32 Cases. (27124923)
2016
6
Pediatric case of microscopic polyangiitis with skin manifestations resembling vesiculobullous type erythema elevatum diutinum with immunoglobulin A antineutrophil cytoplasmic antibody. (27097593)
2016
7
Erythema elevatum diutinum coexisting with ankylosing spondylitis. (27708930)
2015
8
Erythema elevatum diutinum and hypothyroidism: coincidence or causal relationship? (26375227)
2015
9
A case of mistaken identity: unilateral erythema elevatum diutinum associated with IgA paraproteinaemia. (25754401)
2015
10
Erythema elevatum diutinum: an atypical presentation. (25521326)
2015
11
A Case of Erythema Elevatum Diutinum With Pancytopenia: Focus on Dapsone-Induced Hematologic Side Effects and Colchicine as a Safe Treatment Option. (26461818)
2015
12
An atypical distribution of erythema elevatum diutinum. (24479627)
2014
13
Erythema elevatum diutinum in association with dermatitis herpetiformis. (24616856)
2014
14
An unusual case of Sweet syndrome in a child: overlapping presentation with erythema elevatum diutinum. (24521734)
2014
15
Case of Erythema Elevatum Diutinum Associated With IgA Paraproteinemia Successfully Controlled With Thalidomide and Plasma Exchange. (25257541)
2014
16
Erythema Elevatum Diutinum (EED): A Distinctive Vasculitis with Acute-on-Chronic Features. (24652434)
2014
17
Erythema elevatum diutinum: a review of presentation and treatment. (25288365)
2014
18
Nodular Erythema Elevatum Diutinum Mimicking Kaposi's Sarcoma in a Human Immunodeficiency Virus Infected Patient. (25484391)
2014
19
An unusual case of erythema elevatum diutinum with penile and laryngeal manifestations. (24413401)
2014
20
Atypical erythema elevatum diutinum or extrafacial granuloma faciale? (23253514)
2013
21
Erythema elevatum diutinum. (23487831)
2013
22
Erythema elevatum diutinum. (23442466)
2013
23
Associated pyoderma gangrenosum, erythema elevatum diutinum, and Sweet's syndrome: the concept of neutrophilic disease. (24073904)
2013
24
Erythema elevatum diutinum: a new vesiculobullous case. (24001509)
2013
25
Novel use of topical dapsone 5% gel for erythema elevatum diutinum: safer and effective. (23652900)
2013
26
Erythema elevatum diutinum with oral ulceration. (22284024)
2012
27
Successful combination therapy with dapsone and cyclosporine for erythema elevatum diutinum with unusual appearance. (22132683)
2012
28
A case of erythema elevatum diutinum associated with peripheral ulcerative keratitis. (22309340)
2012
29
Alternative procedure to allow continuation of dapsone therapy despite serious adverse reaction in a case of dapsone-sensitive erythema elevatum diutinum. (22508198)
2012
30
Erythema elevatum diutinum associated with peripheral ulcerative keratitis. (20569285)
2011
31
Erythema elevatum diutinum in systemic lupus erythematosus. (20652813)
2011
32
Progressive keratolysis with pseudopterygium associated with erythema elevatum diutinum. (21211842)
2011
33
Acceleration of pulmonary interstitial fibrosis in a patient with myeloperoxidase-antineutrophil cytoplasmic antibody-positive erythema elevatum diutinum. (21839335)
2011
34
Erythema elevatum diutinum: an "idiopathic" case. (21810392)
2011
35
Erythema elevatum diutinum mimicking a vesiculobullous disease. (22126877)
2011
36
Dapsone Hypersensitivity Syndrome That Occurred during Treatment of Pediatric Patient with Erythema Elevatum Diutinum. (22346260)
2011
37
Erythema elevatum diutinum - a chronic leukocytoclastic vasculitis microscopically indistinguishable from granuloma faciale? (21883365)
2011
38
Erythema elevatum diutinum associated with scleritis. (23130212)
2011
39
Erythema elevatum diutinum associated with dermatomyositis. (21496713)
2011
40
Is IgA antineutrophil cytoplasmic antibody a marker for patients with erythema elevatum diutinum? A further three cases demonstrating this association. (21143463)
2011
41
A case of extensive erosive and bullous erythema elevatum diutinum in a patient diagnosed with human immunodeficiency virus (HIV). (21781074)
2011
42
Erythema elevatum diutinum with verrucous carcinoma: a rare association. (20657132)
2010
43
Successful surgical treatment of advanced erythema elevatum diutinum. (21358872)
2010
44
Erythema elevatum diutinum in association with celiac disease. (19570095)
2009
45
Erythema elevatum diutinum as a paraneoplastic syndrome in a patient with pulmonary lymphoepithelioma-like carcinoma. (18571759)
2009
46
Erythema elevatum diutinum presenting with a giant annular pattern. (19261019)
2009
47
An atypical presentation of erythema elevatum diutinum involving palms and soles. (19126056)
2009
48
Erythema elevatum diutinum with unusual clinical appearance. (18266859)
2008
49
Erythema elevatum diutinum with primary SjAPgren syndrome associated with IgA antineutrophil cytoplasmic antibody. (18547305)
2008
50
Erythema elevatum diutinum with rare distribution as a first clinical sign of non-Hodgkin's lymphoma: a novel association? (18477231)
2008

Variations for Erythema Elevatum Diutinum

About this section

Expression for genes affiliated with Erythema Elevatum Diutinum

About this section
Search GEO for disease gene expression data for Erythema Elevatum Diutinum.

Pathways for genes affiliated with Erythema Elevatum Diutinum

About this section

GO Terms for genes affiliated with Erythema Elevatum Diutinum

About this section

Cellular components related to Erythema Elevatum Diutinum according to GeneCards Suite gene sharing:

idNameGO IDScoreTop Affiliating Genes
1external side of plasma membraneGO:00098978.7CD34, CD40LG, CD79A, PECAM1

Biological processes related to Erythema Elevatum Diutinum according to GeneCards Suite gene sharing:

(show all 7)
idNameGO IDScoreTop Affiliating Genes
1B cell proliferationGO:004210010.2CD40LG, CD79A
2glomerular endothelium developmentGO:007201110.2CD34, PECAM1
3positive regulation of interleukin-10 productionGO:003273310.1CD34, CD40LG
4positive regulation of interleukin-4 productionGO:003275310.0CD40LG, GATA3
5lymphocyte migrationGO:00726769.9GATA3, TBX21
6regulation of immune responseGO:00507769.4CD34, CD40LG, TBX21
7T cell differentiationGO:00302179.3GATA3, TBX21

Sources for Erythema Elevatum Diutinum

About this section
2CDC
6CNVD
10DGIdb
15ExPASy
16FDA
17FMA
27GTR
28HGMD
29HMDB
30ICD10
31ICD10 via Orphanet
32ICD9CM
33IUPHAR
34KEGG
37MedGen
39MeSH
40MESH via Orphanet
41MGI
44NCI
45NCIt
46NDF-RT
49NINDS
50Novoseek
52OMIM
53OMIM via Orphanet
57PubMed
58QIAGEN
63SNOMED-CT via Orphanet
67Tumor Gene Family of Databases
68UMLS
69UMLS via Orphanet